Tolerance of Surgical Masks in Chronic Respiratory Diseases
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jul 7, 2022
Trial Information
Current as of April 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the TOLMASK study, is looking at how well different types of surgical masks are tolerated by patients with chronic respiratory diseases, like Chronic Obstructive Pulmonary Disease (COPD). During the COVID-19 pandemic, wearing masks has become essential to help prevent the spread of the virus, but for people with breathing issues, wearing a mask can sometimes make it harder to breathe comfortably. The study aims to find out which mask designs are easier for these patients to wear so that healthcare providers can recommend the best options.
To participate in this study, you need to be at least 18 years old and currently receiving treatment for a respiratory condition at the Pitié-Salpêtrière Hospital. You should also be involved in a rehabilitation program that includes exercise training. However, if you have a tracheostomy, certain psychiatric disorders, or if you cannot speak French well, you may not be eligible. If you join the study, you will be asked to wear different types of masks and report how they affect your breathing and overall comfort. Your participation will help improve mask recommendations for patients with breathing difficulties.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient hospitalised in the respiratory and neuro-respiratory SSR service of the R3S department at the Pitié-Salpêtrière Hospital (Pr Gonzalez-Bermejo)
- • Patient enrolled in a respiratory rehabilitation process including exercise training on a cyclo-ergometer or treadmill
- • Hospitalization in respiratory rehabilitation unit either in post-exacerbation of COPD
- • age over 18
- Exclusion Criteria:
- • Exercise training under mask ventilation support
- • Presence of a tracheostomy
- • Psychiatric disorders (at the discretion of the referring physician)
- • Insufficient command of the French language
- • Refusal to participate in the study
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Thomas SIMILOWSKI, MD
Principal Investigator
Assistance Publique - Hôpitaux de Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials